Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 506428, 8 pages
http://dx.doi.org/10.1155/2015/506428
Research Article

Circulating Soluble Neuropilin-1 in Patients with Early Cervical Cancer and Cervical Intraepithelial Neoplasia Can Be Used as a Valuable Diagnostic Biomarker

1Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Departments of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA
3Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received 26 December 2014; Revised 2 March 2015; Accepted 9 March 2015

Academic Editor: Gad Rennert

Copyright © 2015 Shouhua Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar
  2. A. Stafl and R. F. Mattingly, “Angiogenesis of cervical neoplasia,” American Journal of Obstetrics & Gynecology, vol. 121, no. 6, pp. 845–852, 1975. View at Google Scholar · View at Scopus
  3. G. L. Bremer, A. T. M. G. Tiebosch, H. W. H. M. Van der Putten, H. J. A. Schouten, J. De Haan, and J.-W. Arends, “Tumor angiogenesis: an independent prognostic parameter in cervical cancer,” American Journal of Obstetrics & Gynecology, vol. 174, no. 1, pp. 126–131, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak, “Vascular endothelial growth factor (VEGF) and its receptors,” The FASEB Journal, vol. 13, no. 1, pp. 9–22, 1999. View at Google Scholar · View at Scopus
  5. A. Bagri, M. Tessier-Lavigne, and R. J. Watts, “Neuropilins in tumor biology,” Clinical Cancer Research, vol. 15, no. 6, pp. 1860–1864, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. K. A. Uniewicz, M. J. Cross, and D. G. Fernig, “Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis,” The Journal of Biological Chemistry, vol. 286, no. 1, pp. 12–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature, vol. 407, no. 6801, pp. 249–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Ferrara, H.-P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nature Medicine, vol. 9, no. 6, pp. 669–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Pellet-Many, P. Frankel, H. Jia, and I. Zachary, “Neuropilins: structure, function and role in disease,” Biochemical Journal, vol. 411, no. 2, pp. 211–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Murga, O. Fernandez-Capetillo, and G. Tosato, “Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2,” Blood, vol. 105, no. 5, pp. 1992–1999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Raimondi, A. Fantin, A. Lampropoulou, L. Denti, A. Chikh, and C. Ruhrberg, “Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells,” Journal of Experimental Medicine, vol. 211, no. 6, pp. 1167–1183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Ding, X. Wu, L. Roncari et al., “Expression and regulation of neuropilin-1 in human astrocytomas,” International Journal of Cancer, vol. 88, no. 4, pp. 584–592, 2000. View at Publisher · View at Google Scholar
  13. Q. Ben, J. Zheng, J. Fei et al., “High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma,” Pancreas, vol. 43, pp. 744–749, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Cheng, D. Fu, Z. F. Wei et al., “NRP-1 expression in bladder cancer and its implications for tumor progression,” Tumour Biology, vol. 35, no. 6, pp. 6089–6094, 2014. View at Publisher · View at Google Scholar
  15. J. Xu and J. Xia, “NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo,” Experimental and Therapeutic Medicine, vol. 5, no. 1, pp. 150–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Xu, P. Li, X. Zhang, J. Wang, D. Gu, and Y. Wang, “Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma,” Diagnostic Pathology, vol. 8, no. 1, article no. 155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Jubb, L. A. Strickland, S. D. Liu, J. Mak, M. Schmidt, and H. Koeppen, “Neuropilin-1 expression in cancer and development,” Journal of Pathology, vol. 226, no. 1, pp. 50–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Zhu, H. Cai, M. Tang, and J. Tang, “Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis,” Clinical and Translational Oncology, vol. 16, no. 8, pp. 732–738, 2014. View at Publisher · View at Google Scholar
  19. M. Kreuter, K. Woelke, R. Bieker et al., “Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia,” Leukemia, vol. 20, no. 11, pp. 1950–1954, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Piechnik, A. Dmoszynska, M. Omiotek et al., “The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients,” International Journal of Cancer, vol. 133, no. 6, pp. 1489–1496, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Zhao, L. Gu, C. Li, W. Ma, and Z. Ni, “Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients,” Tumor Biology, vol. 35, no. 7, pp. 6919–6924, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Lu, H. Xiang, P. Liu et al., “Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration,” mAbs, vol. 1, no. 4, pp. 364–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Ochiumi, Y. Kitadai, S. Tanaka et al., “Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer,” International Journal of Oncology, vol. 29, pp. 105–116, 2006. View at Google Scholar
  24. S. A. I. Adham, I. Al Harrasi, I. Al Haddabi et al., “Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer,” Journal of Histochemistry & Cytochemistry, vol. 62, no. 9, pp. 619–631, 2014. View at Publisher · View at Google Scholar
  25. G. M. Delgoffe, S.-R. Woo, M. E. Turnis et al., “Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis,” Nature, vol. 501, no. 7466, pp. 252–256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Chaudhary and E. Elkord, “Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases,” Expert Opinion on Therapeutic Targets, vol. 19, no. 2, pp. 147–161, 2015. View at Publisher · View at Google Scholar
  27. A. Casazza, D. Laoui, M. Wenes et al., “Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity,” Cancer Cell, vol. 24, no. 6, pp. 695–709, 2013. View at Publisher · View at Google Scholar · View at Scopus